Mai H. Bui

Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer

Emily J. Faivre, Keith F. McDaniel, Daniel H. Albert et al. · Nature · 2020 · 389 citations

Bd2 Bromodomain, Medicine, Natural Sciences +9

Micronutrient status and intake in omnivores, vegetarians and vegans in Switzerland

R. Schüpbach, Rita Wegmüller, C. Berguerand et al. · Zeitschrift für Ernährungswissenschaft · 2015 · 300 citations

Nutrition, Nutrient Physiology, Micronutrient Status +8

Discovery of <i>N</i>-(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075/Mivebresib), a Potent and Orally Available Bromodomain and Extraterminal Domain (BET) Family Bromodomain Inhibitor

Keith F. McDaniel, Le Wang, Todd Soltwedel et al. · Journal of Medicinal Chemistry · 2017 · 133 citations · Full text

Selective Chk1 inhibitors differentially sensitize p53‐deficient cancer cells to cancer therapeutics

Zehan Chen, Zhan Xiao, Wen‐Zhen Gu et al. · International Journal of Cancer · 2006 · 129 citations · Full text

Selective Chk1 Inhibitors, Cell Death, Cell Cycle +16

Preclinical Characterization of BET Family Bromodomain Inhibitor ABBV-075 Suggests Combination Therapeutic Strategies

Mai H. Bui, Daniel H. Albert, Leiming Li et al. · Cancer Research · 2017 · 118 citations